Don’t forget – sign up for our free daily newsletter to stay in the activist investing know. Wynnefield Capital is now active on Learning Tree ($LTRE) with a 5.4% stake. It has also sent a letter to the company [letter here]. Two other high-profile fights for Wynnefield has been MusclePharm and Telos.
In terms of Learning Tree, Wynnefield is supporting a “go private” deal, but only at a fair price. Wynnefield doesn’t want to see Learning Tree try and use the NASDAQ delisting as a go dark scheme in an effort to cease having to report publicly.
